Recently, the pharmaceutical industry has shown considerable interest in the en masse micropropagation of elite plants, and the large-scale produc tion of secondary metabolites in plant cell cultures through the use of bioreactors. This is now being realized by the selection of high-yielding somac1ones or through the production of hairy roots by transformation with Agrobacterium rhizogenes. These new developments need to be high-lighted and brought...